The Effect of Yoga Interventions on Cancer-Related Fatigue and Quality of Life for Women with Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
breast cancer
cancer-related fatigue
meta-analysis
physical activity
quality of life
systematic review
yoga
Journal
Integrative cancer therapies
ISSN: 1552-695X
Titre abrégé: Integr Cancer Ther
Pays: United States
ID NLM: 101128834
Informations de publication
Date de publication:
Historique:
entrez:
19
10
2020
pubmed:
20
10
2020
medline:
19
8
2021
Statut:
ppublish
Résumé
Women with breast cancer (BC) are living longer with debilitating side effects such as cancer-related fatigue (CRF) that affect overall well-being. Yoga promotes health, well-being and may be beneficial in reducing CRF. Although there have been previous systematic reviews and meta-analyses, the effects of yoga on CRF and quality of life (QOL) remain unclear, particularly in comparison with other types of physical activity (PA). Our objective is to carry out a systematic review and meta-analysis of the effects of yoga on CRF and QOL in women with BC. Electronic databases were searched (MEDLINE, Embase Classic+Embase and EMB Reviews, Cochrane Central CT) from inception to May 2018. Randomized controlled trials were included if they were full text, in English, included a yoga intervention, a comparator (including non-PA usual care or alternate PA intervention), and reported on CRF or QOL. Effects of yoga were pooled using standardized mean difference (SMD) via a random effects model. Of the 2468 records retrieved, 24 trials were included; 18 studies compared yoga to a non-PA comparator and 6 to a PA comparator. Yoga demonstrated statistically significant improvements in CRF over non-PA (SMD -0.30 [-0.51; -0.08]) but not PA (SMD -0.17 [-0.50; 0.17]) comparators. Additionally, yoga demonstrated statistically significant improvements in QOL over non-PA (SMD -0.27 [-0.46; -0.07]) but not PA (SMD 0.04 [-0.22; +0.31]) comparators. This meta-analysis found that yoga provides small to medium improvements in CRF and QOL compared to non-PA, but not in comparison to other PA interventions.
Sections du résumé
BACKGROUND
Women with breast cancer (BC) are living longer with debilitating side effects such as cancer-related fatigue (CRF) that affect overall well-being. Yoga promotes health, well-being and may be beneficial in reducing CRF. Although there have been previous systematic reviews and meta-analyses, the effects of yoga on CRF and quality of life (QOL) remain unclear, particularly in comparison with other types of physical activity (PA). Our objective is to carry out a systematic review and meta-analysis of the effects of yoga on CRF and QOL in women with BC.
METHODS
Electronic databases were searched (MEDLINE, Embase Classic+Embase and EMB Reviews, Cochrane Central CT) from inception to May 2018. Randomized controlled trials were included if they were full text, in English, included a yoga intervention, a comparator (including non-PA usual care or alternate PA intervention), and reported on CRF or QOL. Effects of yoga were pooled using standardized mean difference (SMD) via a random effects model.
RESULTS
Of the 2468 records retrieved, 24 trials were included; 18 studies compared yoga to a non-PA comparator and 6 to a PA comparator. Yoga demonstrated statistically significant improvements in CRF over non-PA (SMD -0.30 [-0.51; -0.08]) but not PA (SMD -0.17 [-0.50; 0.17]) comparators. Additionally, yoga demonstrated statistically significant improvements in QOL over non-PA (SMD -0.27 [-0.46; -0.07]) but not PA (SMD 0.04 [-0.22; +0.31]) comparators.
DISCUSSION
This meta-analysis found that yoga provides small to medium improvements in CRF and QOL compared to non-PA, but not in comparison to other PA interventions.
Identifiants
pubmed: 33073636
doi: 10.1177/1534735420959882
pmc: PMC7580184
doi:
Types de publication
Journal Article
Meta-Analysis
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1534735420959882Références
Clin Oncol (R Coll Radiol). 2010 Apr;22(3):208-21
pubmed: 20110159
J Altern Complement Med. 2010 Jan;16(1):3-12
pubmed: 20105062
Br J Cancer. 2017 Nov 7;117(10):1442-1449
pubmed: 28926526
Cochrane Database Syst Rev. 2012 Nov 14;11:CD006145
pubmed: 23152233
Geburtshilfe Frauenheilkd. 2013 Apr;73(4):311-317
pubmed: 24771916
Asia Pac J Clin Oncol. 2017 Apr;13(2):e79-e95
pubmed: 25560636
Disabil Rehabil. 2013;35(24):2038-45
pubmed: 23772995
J Nurs Res. 2014 Sep;22(3):155-64
pubmed: 25111109
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
PLoS One. 2012;7(4):e34916
pubmed: 22514690
Ann Intern Med. 2009 Aug 18;151(4):264-9, W64
pubmed: 19622511
J Phys Act Health. 2015 May;12(5):675-9
pubmed: 24834485
CA Cancer J Clin. 2012 Jul-Aug;62(4):243-74
pubmed: 22539238
Cancer Control. 2005 Jul;12(3):165-71
pubmed: 16062164
Support Care Cancer. 2012 Dec;20(12):3055-64
pubmed: 23052917
Explore (NY). 2013 Jul-Aug;9(4):232-43
pubmed: 23906102
Evid Based Complement Alternat Med. 2016;2016:5931816
pubmed: 27019663
Evid Based Complement Alternat Med. 2012;2012:124703
pubmed: 22991569
Eur J Cancer Care (Engl). 2010 Nov;19(6):761-8
pubmed: 19832890
Cancer Nurs. 2007 Sep-Oct;30(5):E35-45
pubmed: 17876176
J Natl Compr Canc Netw. 2010 Dec;8(12):1331-9
pubmed: 21147900
Br J Sports Med. 2018 May;52(10):651-658
pubmed: 28501804
Support Care Cancer. 2016 Sep;24(9):4005-15
pubmed: 27129840
Complement Ther Clin Pract. 2015 Feb;21(1):7-10
pubmed: 25697379
J Clin Oncol. 2007 Oct 1;25(28):4387-95
pubmed: 17785709
Phys Ther. 2010 Aug;90(8):1135-47
pubmed: 20558566
Cancer Epidemiol Biomarkers Prev. 2011 Jan;20(1):123-33
pubmed: 21051654
BMC Cancer. 2012 Nov 27;12:559
pubmed: 23181734
Cancer. 2015 Jul 1;121(13):2175-84
pubmed: 25739642
J Cancer Res Clin Oncol. 2016 Dec;142(12):2523-2540
pubmed: 27630024
Cancer. 2012 Apr 15;118(8 Suppl):2261-9
pubmed: 22488700
J Racial Ethn Health Disparities. 2018 Feb;5(1):62-72
pubmed: 28411330
Am J Phys Med Rehabil. 2014 Aug;93(8):675-86
pubmed: 24743466
ScientificWorldJournal. 2014 Jan 19;2014:271828
pubmed: 24563628
Psychooncology. 2013 Jan;22(1):186-94
pubmed: 23296635
BMC Complement Altern Med. 2014 Jul 01;14:214
pubmed: 24980836
Ann Oncol. 2009 Jan;20(1):17-25
pubmed: 18678767
Psychooncology. 2009 Apr;18(4):360-8
pubmed: 19242916
Complement Ther Med. 2009 Oct-Dec;17(5-6):274-80
pubmed: 19942107
Support Care Cancer. 2018 Mar;26(3):905-912
pubmed: 28965138
Acta Oncol. 2011 Feb;50(2):187-93
pubmed: 21231780
Crit Rev Oncol Hematol. 2018 Feb;122:52-59
pubmed: 29458789
Am Surg. 2010 Sep;76(9):962-5
pubmed: 20836343
Glob Adv Health Med. 2012 Nov;1(5):30-5
pubmed: 27257529
J Clin Oncol. 2014 Apr 1;32(10):1040-9
pubmed: 24470004
J Soc Integr Oncol. 2010 Spring;8(2):43-55
pubmed: 20388445
J Am Acad Nurse Pract. 2011 Mar;23(3):135-42
pubmed: 21355946
Evid Based Complement Alternat Med. 2011;2011:659876
pubmed: 21437197
BMJ. 2011 Oct 18;343:d5928
pubmed: 22008217
Prz Menopauzalny. 2014 Jun;13(3):186-93
pubmed: 26327853
Cancer. 2012 Aug 1;118(15):3766-75
pubmed: 22180393
Cancer Nurs. 2011 Jul-Aug;34(4):322-34
pubmed: 21116178
Psychooncology. 2006 Oct;15(10):891-7
pubmed: 16374892
JAMA Oncol. 2017 Jul 1;3(7):961-968
pubmed: 28253393
Support Care Cancer. 2012 Feb;20(2):267-77
pubmed: 21207071
Integr Cancer Ther. 2015 Mar;14(2):125-32
pubmed: 25567329
J Clin Oncol. 2014 Apr 1;32(10):1058-65
pubmed: 24590636
Indian J Palliat Care. 2017 Jul-Sep;23(3):247-252
pubmed: 28827926